{"id":1008426,"date":"2026-10-08T05:12:29","date_gmt":"2026-10-08T09:12:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/"},"modified":"2026-10-08T05:12:29","modified_gmt":"2026-10-08T09:12:29","slug":"brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/","title":{"rendered":"Brink’s Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos"},"content":{"rendered":"
\n

\n Divestiture of NoteMachine\/TestLink UK to avoid a CMA Phase 2 referral<\/em>\n <\/p>\n

\n Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027<\/em>\n <\/p>\n

RICHMOND, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) — The Brink’s Company (NYSE: BCO) (\u201cBrink\u2019s\u201d or \u201cthe Company\u201d) announced today that the United Kingdom’s Competition and Markets Authority (“CMA”) has accepted in principle Brink\u2019s proposed remedy for its planned acquisition of NCR Atleos Corporation (NYSE: NATL) (\u201cNCR Atleos\u201d).<\/p>\n

Brink’s has been working constructively with the CMA to establish that the divestiture of NoteMachine\/TestLink UK is an acceptable remedy (or “undertaking in lieu” of a referral for a Phase 2 investigation) to address the UK-specific concerns that the CMA shared with Brink\u2019s early in the review process. Brink\u2019s is committed to selecting a suitable buyer and concluding the divestiture process in a timely manner in order to avoid the CMA referring the acquisition to a Phase 2 investigation. As previously announced on September 30, 2026, the sale process is progressing, and Brink\u2019s remains engaged with a number of prospective buyers.<\/p>\n

“We are pleased with the CMA\u2019s acceptance in principle of the proposed remedy, as this represents a significant step forward, and we appreciate the CMA’s constructive and timely engagement throughout the process,” said Mark Eubanks, President and Chief Executive Officer of Brink’s. “The potential sale of NoteMachine\/TestLink UK was a remedy that was contemplated in the financial metrics that Brink\u2019s has previously disclosed and does not impact the $200 million in annual run-rate cost synergies that we continue to expect to achieve within three years of closing the transaction. We continue to make progress towards the successful completion of our pending acquisition of NCR Atleos and look forward to positioning the combined business to deliver enhanced customer solutions and accelerate our value creation strategy.”<\/p>\n

Brink’s acquisition of NCR Atleos remains on track to close early in the first quarter of 2027.<\/p>\n

\n About The Brink\u2019s Company<\/strong>\u00a0
The Brink\u2019s Company (NYSE:\u00a0BCO)\u00a0is\u00a0a leading global provider of cash and valuables management, digital retail solutions, and ATM managed services. Our customers include financial institutions, retailers, government agencies, mints,\u00a0jewelers\u00a0and other commercial operations. Our network of operations in 51 countries serves customers in more than 100 countries. For more information, please visit our website at www.brinks.com<\/a>.\u00a0<\/p>\n

\n Forward-Looking Statements\u00a0<\/strong>
\n
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as \u201canticipate,\u201d \u201cassume,\u201d \u201ccan,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201ctarget,\u201d \u201cpossible,\u201d \u201cproject,\u201d \u201cpredict,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cpotential,\u201d \u201cmay,\u201d \u201cshould\u201d, \u201cwill\u201d and similar expressions are based on current expectations and assumptions and are subject to risks, uncertainties and contingencies, many of which are beyond our control and difficult to predict or quantify, and which could cause actual results to differ materially from those that are anticipated.<\/p>\n

Factors that could cause actual results to differ include, but are not limited to: Brink\u2019s ability to consummate the acquisition of NCR Atleos (the \u201cTransaction\u201d); the occurrence of any event, change or other circumstance that could give rise to the termination of the definitive agreement with respect to the Transaction; Brink\u2019s ability to finance the Transaction; Brink\u2019s indebtedness, including the substantial indebtedness Brink\u2019s will incur in connection with the Transaction and the need to generate sufficient cash flows to service and repay such indebtedness; failure to consummate any anticipated repayment of the combined company\u2019s indebtedness or make any returns to shareholders in the expected timeframe or at all; failure to obtain applicable regulatory approvals in a timely manner or otherwise; failure to satisfy any other conditions to closing of the Transaction; failure to realize the anticipated benefits and synergies of the Transaction in the expected timeframe or at all, including as a result of a delay in consummating the Transaction; the success of integration plans and the time required to successfully integrate NCR Atleos\u2019 operations with those of Brink\u2019s; the focus of management\u2019s time and attention on the Transaction and other potential disruptions arising from the Transaction; the effects of the announcement of the Transaction on Brink\u2019s or NCR Atleos\u2019 businesses; that operating costs, customer loss and business disruption (including, without limitation, difficulties in maintaining relationships with banks, employees, customers or suppliers) may be greater than expected following the public announcement of the Transaction; Brink\u2019s or NCR Atleos\u2019 ability to retain certain key employees following the public announcement of the Transaction; litigation related to the Transaction; Brink\u2019s or NCR Atleos\u2019 ability to obtain certain third party or governmental regulatory consents, approvals or clearances; potential undisclosed liabilities of NCR Atleos not identified during the due diligence process; the impact of the Transaction on the market price of Brink\u2019s or NCR Atleos\u2019 common stock and\/or operating results; and general economic conditions that are less favorable than expected.<\/p>\n

Additional information concerning other risk factors is also contained in Part I, Item 1A \u201cRisk Factors\u201d of (i) Brink\u2019s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026, and (ii) NCR Atleos\u2019 Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 27, 2026 and, in each case, in subsequent filings with the SEC.<\/p>\n

The forward-looking information included in this press release is representative only as of the date of the communications included in this press release and Brink\u2019s and NCR Atleos undertake no obligation to update, revise or clarify any information contained in this press release or forward-looking statements that may be made from time to time on either of their behalf, whether as a result of new information, future events or otherwise, except as required by law.<\/p>\n

\n Contacts<\/strong>\u00a0
Investor\u00a0Inquiries<\/em>\u00a0
Jesse Jenkins\u00a0
jesse.jenkins@brinksinc.com\u00a0<\/p>\n

\n Media\u00a0Inquiries<\/em>\u00a0
Kelly\u00a0McNeff\u00a0
(469) 549-6555\u00a0
brinksmedia@brinks.com\u00a0<\/p>\n

OR\u00a0<\/p>\n

FGS Global\u00a0
brinks@fgsglobal.com<\/a>\u00a0\u00a0<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Divestiture of NoteMachine\/TestLink UK to avoid a CMA Phase 2 referral Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027 RICHMOND, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) — The Brink’s Company (NYSE: BCO) (\u201cBrink\u2019s\u201d or \u201cthe Company\u201d) announced today that the United Kingdom’s Competition and Markets Authority (“CMA”) has accepted in principle Brink\u2019s proposed remedy for its planned acquisition of NCR Atleos Corporation (NYSE: NATL) (\u201cNCR Atleos\u201d). Brink’s has been working constructively with the CMA to establish that the divestiture of NoteMachine\/TestLink UK is an acceptable remedy (or “undertaking in lieu” of a referral for a Phase 2 investigation) to address the UK-specific concerns that the CMA shared with Brink\u2019s early in the … <\/p>\n

Continue reading “Brink’s Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1008426","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBrink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Divestiture of NoteMachine\/TestLink UK to avoid a CMA Phase 2 referral Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027 RICHMOND, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) — The Brink’s Company (NYSE: BCO) (\u201cBrink\u2019s\u201d or \u201cthe Company\u201d) announced today that the United Kingdom’s Competition and Markets Authority (“CMA”) has accepted in principle Brink\u2019s proposed remedy for its planned acquisition of NCR Atleos Corporation (NYSE: NATL) (\u201cNCR Atleos\u201d). Brink’s has been working constructively with the CMA to establish that the divestiture of NoteMachine\/TestLink UK is an acceptable remedy (or “undertaking in lieu” of a referral for a Phase 2 investigation) to address the UK-specific concerns that the CMA shared with Brink\u2019s early in the … Continue reading "Brink’s Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-08T09:12:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjA4MyM3ODgxNjM5IzIwMTY5OTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Brink’s Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos\",\"datePublished\":\"2026-10-08T09:12:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\\\/\"},\"wordCount\":990,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0MjA4MyM3ODgxNjM5IzIwMTY5OTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\\\/\",\"name\":\"Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0MjA4MyM3ODgxNjM5IzIwMTY5OTM=\",\"datePublished\":\"2026-10-08T09:12:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0MjA4MyM3ODgxNjM5IzIwMTY5OTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0MjA4MyM3ODgxNjM5IzIwMTY5OTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brink’s Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/","og_locale":"en_US","og_type":"article","og_title":"Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos - Market Newsdesk","og_description":"Divestiture of NoteMachine\/TestLink UK to avoid a CMA Phase 2 referral Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027 RICHMOND, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) — The Brink’s Company (NYSE: BCO) (\u201cBrink\u2019s\u201d or \u201cthe Company\u201d) announced today that the United Kingdom’s Competition and Markets Authority (“CMA”) has accepted in principle Brink\u2019s proposed remedy for its planned acquisition of NCR Atleos Corporation (NYSE: NATL) (\u201cNCR Atleos\u201d). Brink’s has been working constructively with the CMA to establish that the divestiture of NoteMachine\/TestLink UK is an acceptable remedy (or “undertaking in lieu” of a referral for a Phase 2 investigation) to address the UK-specific concerns that the CMA shared with Brink\u2019s early in the … Continue reading \"Brink’s Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-08T09:12:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjA4MyM3ODgxNjM5IzIwMTY5OTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Brink’s Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos","datePublished":"2026-10-08T09:12:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/"},"wordCount":990,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjA4MyM3ODgxNjM5IzIwMTY5OTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/","name":"Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjA4MyM3ODgxNjM5IzIwMTY5OTM=","datePublished":"2026-10-08T09:12:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjA4MyM3ODgxNjM5IzIwMTY5OTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjA4MyM3ODgxNjM5IzIwMTY5OTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brinks-receives-cma-acceptance-in-principle-of-proposed-remedy-relating-to-pending-acquisition-of-ncr-atleos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Brink’s Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1008426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1008426"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1008426\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1008426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1008426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1008426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}